JGBO DD update / Jiangbo Pharmaceuticals still got 4 own drugs in FINAL developments...not talking about what they acquired earlier with that university acquisition ontop (22 products) !!
11 products already selling and we know they sell good and with high margins. Saying they are lined up to serve the whole chinese market isnt that wrong aswell..hm ? LOL ! We do have a real winner here imo and many do still not know that company , lets see what happens when we get uplisting news sooner or later !!!
Product Name Use Stage
Ligustrazine Ferulic Acid Acetate (LFAA) Reduces blood clotting and prevents platelets in the blood from clumping together Undergoing Phase III (final) clinical studies
Felodipine Sustained Release Tablets Treats high blood pressure and arteriosclerosis. Pending final SFDA approval
Yuandu Hanbi Capsules Relief arthritis pain – Traditional Chinese Medicine Pending final SFDA approval
Bezoar Yijin Tablets Cures inflammations such as pharyngitis Pending final SFDA approval
Longterm Investment, Biotechs & High Yield Dividend Stocks ...#board-11828
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.